Press-release for stocks for AMGN

symbols : AMGN

save search

Xencor Reports Third Quarter 2023 Financial Results
Published: 2023-11-07 (Crawled : 00:00) - biospace.com/
XNCR | $19.05 3.7% 3.57% 760K

Health Technology

| -0.16% | O: -0.05% H: 1.41% C: 0.82%
OMER | $3.04 -1.62% -1.64% 250K

Health Technology

| 127.21% | O: -1.47% H: 11.57% C: 5.97%
MOR | News | $18.07 0.17% 0.17% 130K

Health Technology

| 118.93% | O: 0.36% H: 0.48% C: -1.09%
GILD | $67.07 0.06% 0.06% 8.3M

Health Technology

| -17.39% | O: -0.09% H: 0.35% C: -0.57%
AMGN | News | $273.085 -0.17% -0.17% 2.5M

Health Technology

| 0.26% | O: 0.05% H: 0.38% C: -0.68%
financial results

AMGEN PRESENTS NEW RESEARCH IN EARLY PSORIATIC ARTHRITIS AT ACR 2023
Published: 2023-11-07 (Crawled : 21:00) - prnewswire.com
BGNE | $144.0 3.61% 3.48% 220K

Health Technology

| -29.7% | O: 0.66% H: 1.5% C: 0.61%
AMGN | News | $273.085 -0.17% -0.17% 2.5M

Health Technology

| 0.9% | O: 0.48% H: 0.86% C: 0.31%
research

Epidemiology and Genetics of Clonal Hematopoiesis, a Premalignant Hematopoietic Stem Cell Condition
Published: 2023-11-06 (Crawled : 16:00) - prnewswire.com
AMGN | News | $273.085 -0.17% -0.17% 2.5M

Health Technology

| 1.36% | O: 0.34% H: 1.54% C: 0.76%
cell

Gene Therapy Market size to grow by USD 4.61 billion from 2022 to 2027, North America to account for 39% of market growth- Technavio
Published: 2023-11-03 (Crawled : 23:00) - prnewswire.com
BIIB | $201.91 4.52% 4.32% 3.3M

Health Technology

| Email alert Add to watchlist
NVSEF | News | $96.0 6.88% 52K

Health Technology

| Email alert Add to watchlist
ALPMF | News | $9.5 43.47% 1.2K

Health Technology

| Email alert Add to watchlist
ORTX | $16.7 0.0% 370K

Health Technology

| Email alert Add to watchlist
ABEO | News | $3.165 -7.19% -7.74% 2.2M

Health Technology

| Email alert Add to watchlist
AMGN | News | $273.085 -0.17% -0.17% 2.5M

Health Technology

| Email alert Add to watchlist
GBIO | News | $2.995 -8.13% -8.85% 110K

Health Technology

| Email alert Add to watchlist
ADAP | $1.085 -4.83% -5.07% 780K

Health Technology

| Email alert Add to watchlist
AAPL | $168.99 1.25% 1.24% 48M

Electronic Technology

| Email alert Add to watchlist
NVS | News | $98.35 1.1% 0.0% 2.2M

Health Technology

| Email alert Add to watchlist
ALPMY | News | $9.49 -1.11% 480K

Manufacturing

| Email alert Add to watchlist
america therapy market

Key Players Such as AbbVie, Roche, and Amgen Dominate the Competitive Landscape of the Expanding Cytokine Market
Published: 2023-11-03 (Crawled : 01:00) - prnewswire.com
UCBJF | $128.725 -39.66% 750

Health Technology

| 71.51% | O: -1.4% H: 0.0% C: 0.0%
UCBJY | $65.26 -4.38% 5.9K

Manufacturing

| 78.11% | O: 0.48% H: 1.02% C: 0.42%
TMO | News | $577.39 0.49% 0.0% 2M

Health Technology

| 27.24% | O: 2.32% H: 0.0% C: 0.0%
ABBV | News | $167.8 -1.03% -0.06% 4.1M

Health Technology

| 20.04% | O: 1.88% H: 0.0% C: 0.0%
TECH | $63.48 -0.33% -0.33% 980K

Health Technology

| 14.94% | O: 2.71% H: 4.38% C: 3.18%
AMGN | News | $273.085 -0.17% -0.17% 2.5M

Health Technology

| 2.61% | O: 0.72% H: 0.76% C: 0.5%
ABCM | News | $23.99 0.0% 7.4M

Health Technology

| 3.63% | O: 0.0% H: 0.0% C: 0.0%
market

AMGEN PRESENTS NEW DATA THAT SHOW BLOOD PRESSURE DECREASES FOR ADULTS TREATED WITH KRYSTEXXA® (PEGLOTICASE)
Published: 2023-11-02 (Crawled : 14:00) - biospace.com/
BGNE | $144.0 3.61% 3.48% 220K

Health Technology

| -23.34% | O: 0.5% H: 2.69% C: -0.09%
AMGN | News | $273.085 -0.17% -0.17% 2.5M

Health Technology

| 4.87% | O: 0.94% H: 1.82% C: 1.25%
krystexxa blood show

SpringWorks Therapeutics Reports Third Quarter 2023 Financial Results and Recent Business Highlights
Published: 2023-11-02 (Crawled : 11:00) - globenewswire.com
SWTX | $43.37 -1.43% -1.45% 470K

Health Technology

| 84.02% | O: 4.14% H: 6.22% C: 1.41%
BGNE | $144.0 3.61% 3.48% 220K

Health Technology

| -23.34% | O: 0.5% H: 2.69% C: -0.09%
AMGN | News | $273.085 -0.17% -0.17% 2.5M

Health Technology

| 4.87% | O: 0.94% H: 1.82% C: 1.25%
business therapeutics financial results

AMGEN TO PRESENT DATA AT ACR 2023 ACROSS EXPANDED RHEUMATOLOGY PIPELINE AND PORTFOLIO
Published: 2023-11-01 (Crawled : 20:00) - biospace.com/
BGNE | $144.0 3.61% 3.48% 220K

Health Technology

| -25.39% | O: -1.12% H: 1.26% C: -1.57%
AMGN | News | $273.085 -0.17% -0.17% 2.5M

Health Technology

| 6.98% | O: 0.22% H: 1.92% C: 1.78%
pipeline

Biosimilars market size to increase by USD 42.22 billion | The regulatory landscape regarding therapeutic interchangeability across different countries is the market trend - Technavio
Published: 2023-11-01 (Crawled : 09:00) - prnewswire.com
ABBV | News | $167.8 -1.03% -0.06% 4.1M

Health Technology

| 19.59% | O: 0.06% H: 1.3% C: 0.43%
BIIB | $201.91 4.52% 4.32% 3.3M

Health Technology

| -18.67% | O: 0.43% H: 1.05% C: 0.44%
AMGN | News | $273.085 -0.17% -0.17% 2.5M

Health Technology

| 6.98% | O: 0.22% H: 1.92% C: 1.78%
market

AMGEN REPORTS THIRD QUARTER FINANCIAL RESULTS
Published: 2023-10-31 (Crawled : 11:00) - prnewswire.com
SNYNF | News | $94.25 -2.18% 480

Health Technology

| 6.51% | O: 4.66% H: 0.0% C: -3.51%
BMY | $48.86 -0.27% -0.02% 16M

Health Technology

| -4.41% | O: 0.25% H: 0.54% C: 0.29%
XNCR | $19.05 3.7% 3.57% 760K

Health Technology

| 6.62% | O: -0.41% H: 2.1% C: 1.11%
SNY | News | $46.66 -2.16% -2.21% 1.7M

Health Technology

| 5.99% | O: 2.61% H: 0.0% C: 0.0%
REGN | News | $906.55 -0.09% -0.08% 370K

Health Technology

| 16.67% | O: -0.33% H: 0.92% C: 0.61%
BGNE | $144.0 3.61% 3.48% 220K

Health Technology

| -25.52% | O: 0.14% H: 0.68% C: -0.32%
AMGN | News | $273.085 -0.17% -0.17% 2.5M

Health Technology

| 3.93% | O: -2.77% H: 0.6% C: -0.07%
financial results

PacBio Announces Third Quarter 2023 Financial Results
Published: 2023-10-30 (Crawled : 20:00) - prnewswire.com
MMM | $92.02 -1.05% 0.0% 3.8M

Producer Manufacturing

| 3.89% | O: -0.04% H: 2.34% C: 1.64%
PACB | $1.355 -7.82% -8.49% 11M

Health Technology

| -79.32% | O: -5.34% H: 0.59% C: -8.17%
AMGN | News | $273.085 -0.17% -0.17% 2.5M

Health Technology

| 3.93% | O: -2.77% H: 0.6% C: -0.07%
financial results

Increasing Prevalence of Laryngeal Cancer Fuels Growth in Laryngeal Cancer Therapeutics Market
Published: 2023-10-27 (Crawled : 02:00) - prnewswire.com
SNYNF | News | $94.25 -2.18% 480

Health Technology

| -10.45% | O: -18.18% H: 0.0% C: 0.0%
AZNCF | News | $140.3 -4.19% 1.5K

Health Technology

| 11.99% | O: -1.1% H: 0.18% C: -1.98%
SNY | News | $46.66 -2.16% -2.21% 1.7M

Health Technology

| -11.44% | O: -15.73% H: 0.0% C: 0.0%
AZN | News | $71.175 0.46% 0.46% 6.1M

Health Technology

| 11.73% | O: -0.42% H: 0.13% C: -1.99%
AMGN | News | $273.085 -0.17% -0.17% 2.5M

Health Technology

| 1.42% | O: -0.28% H: 0.15% C: -2.74%
cancer therapeutics growth market

A large international study of migraine reveals new biological pathways for treatment
Published: 2023-10-26 (Crawled : 18:00) - biospace.com/
AMGN | News | $273.085 -0.17% -0.17% 2.5M

Health Technology

| 0.51% | O: -0.24% H: 0.71% C: -0.66%
international treatment migraine study

AMGEN ANNOUNCES WEBCAST OF 2023 THIRD QUARTER FINANCIAL RESULTS
Published: 2023-10-25 (Crawled : 23:00) - biospace.com/
AMGN | News | $273.085 -0.17% -0.17% 2.5M

Health Technology